Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tiagabine

S Shinnar1

  • 1Comprehensive Epilepsy Management Center, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Seminars in Pediatric Neurology
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Tiagabine effectively treats partial seizures in adults and adolescents by blocking GABA uptake. Preliminary pediatric data suggest potential efficacy in children as well.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Evaluation of Medial Temporal Lobe Morphology in Children with Febrile Status Epilepticus: Results of the FEBSTAT Study.

AJNR. American journal of neuroradiology·2016
Same author

Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Epilepsy currents·2015
Same author

Long-term association between seizure outcome and depression after resective epilepsy surgery.

Neurology·2011
Same author

The role of EEG in febrile status epilepticus (FSE).

Brain & development·2009
Same author

Prevalence of hippocampal malrotation in a population without seizures.

AJNR. American journal of neuroradiology·2009
Same author

Phenomenology of prolonged febrile seizures: results of the FEBSTAT study.

Neurology·2008
Same journal

Concussion in contact sport: risks, detection, & prevention.

Seminars in pediatric neurology·2026
Same journal

A multidisciplinary, symptom-targeted approach to rehabilitation in pediatric concussion.

Seminars in pediatric neurology·2026
Same journal

Pediatric concussion beyond sports: Falls, play, and everyday activities.

Seminars in pediatric neurology·2026
Same journal

Return-to-school protocols in pediatric concussion care.

Seminars in pediatric neurology·2026
Same journal

Improving concussion recognition in youth sports: the role of parents, coaches, and community education.

Seminars in pediatric neurology·2026
Same journal

Concussion management, rehabilitation, and societal impact.

Seminars in pediatric neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Epilepsy is a neurological disorder characterized by recurrent seizures.
  • Partial seizures are the most common type of epileptic seizure.
  • Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain.

Purpose of the Study:

  • To review the pharmacokinetics, efficacy, and safety of tiagabine.
  • To evaluate tiagabine's potential as an antiepileptic drug.

Main Methods:

  • Review of preclinical animal studies.
  • Analysis of clinical trial data in adults and adolescents.
  • Assessment of preliminary pediatric data.

Main Results:

  • Tiagabine demonstrated efficacy in treating partial seizures in adults and adolescents.
  • Animal and human data support the pharmacokinetic profile of tiagabine.
  • Preliminary pediatric data indicate promising results.

    • Conclusions:

    • Tiagabine is a promising antiepileptic drug for partial seizures.
    • Further research is warranted to confirm efficacy and safety in pediatric populations.